162 related articles for article (PubMed ID: 37022192)
1. Combined Methylation and Transcriptome Analysis of Liver Injury of Nonalcoholic Fatty Liver Disease Induced by High Alcohol-Producing Klebsiella pneumoniae.
Zhang R; Xu Z; Xue G; Feng J; Du B; Gan L; Fan Z; Fu T; Feng Y; Zhao H; Cui J; Yan C; Cui X; Tian Z; Chen J; Yu Z; Yuan J
Microbiol Spectr; 2023 Jun; 11(3):e0532322. PubMed ID: 37022192
[TBL] [Abstract][Full Text] [Related]
2. Glucose Induces Resistance to Polymyxins in High-Alcohol-Producing Klebsiella pneumoniae via Increasing Capsular Polysaccharide and Maintaining Intracellular ATP.
Fan Z; Fu T; Liu H; Li Z; Du B; Cui X; Zhang R; Feng Y; Zhao H; Xue G; Cui J; Yan C; Gan L; Feng J; Xu Z; Yu Z; Tian Z; Ding Z; Chen J; Chen Y; Yuan J
Microbiol Spectr; 2023 Aug; 11(4):e0003123. PubMed ID: 37338347
[TBL] [Abstract][Full Text] [Related]
3. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.
Yuan J; Chen C; Cui J; Lu J; Yan C; Wei X; Zhao X; Li N; Li S; Xue G; Cheng W; Li B; Li H; Lin W; Tian C; Zhao J; Han J; An D; Zhang Q; Wei H; Zheng M; Ma X; Li W; Chen X; Zhang Z; Zeng H; Ying S; Wu J; Yang R; Liu D
Cell Metab; 2019 Oct; 30(4):675-688.e7. PubMed ID: 31543403
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae.
Gan L; Feng Y; Du B; Fu H; Tian Z; Xue G; Yan C; Cui X; Zhang R; Cui J; Zhao H; Feng J; Xu Z; Fan Z; Fu T; Du S; Liu S; Zhang Q; Yu Z; Sun Y; Yuan J
Nat Commun; 2023 Jun; 14(1):3215. PubMed ID: 37270557
[TBL] [Abstract][Full Text] [Related]
5. High alcohol-producing
Li NN; Li W; Feng JX; Zhang WW; Zhang R; Du SH; Liu SY; Xue GH; Yan C; Cui JH; Zhao HQ; Feng YL; Gan L; Zhang Q; Chen C; Liu D; Yuan J
Gut Microbes; 2021; 13(1):1979883. PubMed ID: 34632939
[TBL] [Abstract][Full Text] [Related]
6. The role of integration host factor in biofilm and virulence of high-alcohol-producing
Fan Z; Fu T; Li Z; Du B; Cui X; Zhang R; Feng Y; Zhao H; Xue G; Cui J; Yan C; Gan L; Feng J; Xu Z; Yu Z; Tian Z; Ding Z; Chen J; Chen Y; Yuan J
Microbiol Spectr; 2023 Sep; 11(5):e0117023. PubMed ID: 37732783
[No Abstract] [Full Text] [Related]
7. Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease.
Chen X; Zhang Z; Li H; Zhao J; Wei X; Lin W; Zhao X; Jiang A; Yuan J
J Gastroenterol Hepatol; 2020 Nov; 35(11):2009-2019. PubMed ID: 32150306
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome DNA methylation and gene expression profiling in the livers of mice with nonalcoholic steatohepatitis.
Bi H; Zhou B; Yang J; Lu Y; Mao F; Song Y
Life Sci; 2023 Sep; 329():121951. PubMed ID: 37473799
[TBL] [Abstract][Full Text] [Related]
9. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
[TBL] [Abstract][Full Text] [Related]
10. RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis.
Kim JY; Yang IS; Kim HJ; Yoon JY; Han YH; Seong JK; Lee MO
Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E118-E131. PubMed ID: 34894722
[TBL] [Abstract][Full Text] [Related]
11. Three Klebsiella species as potential pathobionts generating endogenous ethanol in a clinical cohort of patients with auto-brewery syndrome: a case control study.
Xue G; Feng J; Zhang R; Du B; Sun Y; Liu S; Yan C; Liu X; Du S; Feng Y; Cui J; Gan L; Zhao H; Fan Z; Cui X; Xu Z; Fu T; Li C; Huang L; Zhang T; Wang J; Yang R; Yuan J
EBioMedicine; 2023 May; 91():104560. PubMed ID: 37060744
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation in Nonalcoholic Fatty Liver Disease.
Hyun J; Jung Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143364
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease.
Fei N; Bruneau A; Zhang X; Wang R; Wang J; Rabot S; Gérard P; Zhao L
mBio; 2020 Feb; 11(1):. PubMed ID: 32019793
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
15. Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy.
Qiu J; Chen L; Zhang L; Xu F; Zhang C; Ren G; Chang K; He G; Du Z; Le Y; Yu Z; Li S; Liu Q; Dou X
Phytomedicine; 2023 Dec; 121():155111. PubMed ID: 37804819
[TBL] [Abstract][Full Text] [Related]
16. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
[TBL] [Abstract][Full Text] [Related]
17. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
18. The role of ADIPOQ methylation in curcumin-administrated experimental nonalcoholic fatty liver disease.
Chen WJ; Cai B; Chen HT; Cao CY; Du YL; Li YY; Nie YQ; Zhou YJ
J Dig Dis; 2016 Dec; 17(12):829-836. PubMed ID: 27860427
[TBL] [Abstract][Full Text] [Related]
19. Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice.
Tryndyak VP; Han T; Fuscoe JC; Ross SA; Beland FA; Pogribny IP
BMC Genomics; 2016 Apr; 17():298. PubMed ID: 27103143
[TBL] [Abstract][Full Text] [Related]
20. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
